Diet, Epigenetic, and Cancer Prevention

Advances in Genetics

Volumn 71, Issue C, 2010, Pages 237-255

  Chen, Jia ^a   Xu, Xinran ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; MICRORNA;

ANIMAL; CLINICAL TRIAL; DIET; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MICRORNAS; NEOPLASMS;

EID: 77957378106     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380864-6.00008-0     Document Type: Book

References (94)

1. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003, 23:363-398.
2. Ahn W.S., Yoo J., Huh S.W., Kim C.K., Lee J.M., Namkoong S.E., Bae S.M., Lee I.P. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 2003, 12:383-390.
3. Asada K., Kotake Y., Asada R., Saunders D., Broyles R.H., Towner R.A., Fukui H., Floyd R.A. LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J. Biomed. Biotechnol. 2006, 2006:17142.
4. Berletch J.B., Liu C., Love W.K., Andrews L.G., Katiyar S.K., Tollefsbol T.O. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell. Biochem. 2008, 103:509-519.
5. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
6. Camporeale G., Shubert E.E., Sarath G., Cerny R., Zempleni J. K8 and K12 are biotinylated in human histone H4. Eur. J. Biochem. 2004, 271:2257-2263.
7. Camporeale G., Giordano E., Rendina R., Zempleni J., Eissenberg J.C. Drosophila melanogaster holocarboxylase synthetase is a chromosomal protein required for normal histone biotinylation, gene transcription patterns, lifespan, and heat tolerance. J. Nutr. 2006, 136:2735-2742.
8. Camporeale G., Oommen A.M., Griffin J.B., Sarath G., Zempleni J. K12-biotinylated histone H4 marks heterochromatin in human lymphoblastoma cells. J. Nutr. Biochem. 2007, 18:760-768.
9. Camporeale G., Zempleni J., Eissenberg J.C. Susceptibility to heat stress and aberrant gene expression patterns in holocarboxylase synthetase-deficient drosophila melanogaster are caused by decreased biotinylation of histones, not of carboxylases. J. Nutr. 2007, 137:885-889.
10. Chen J., Xu X., Liu A., Ulrich C.M. Folate and cancer: epidemiological perspective. Folate in Health and Disease 2009, 190-230. CRC Press. 2nd edn. L.B. Bailey (Ed.).
11. Chew Y.C., Camporeale G., Kothapalli N., Sarath G., Zempleni J. Lysine residues in N-terminal and C-terminal regions of human histone H2A are targets for biotinylation by biotinidase. J. Nutr. Biochem. 2006, 17:225-233.
12. Christman J.K., Sheikhnejad G., Dizik M., Abileah S., Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993, 14:551-557.
13. Clausen M.R., Bonnen H., Mortensen P.B. Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut 1991, 32:923-928.
14. Cole B.F., Baron J.A., Sandler R.S., Haile R.W., Ahnen D.J., Bresalier R.S., McKeown-Eyssen G., Summers R.W., Rothstein R.I., Burke C.A., Snover D.C., Church T.R., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 2007, 297:2351-2359.
15. Cravo M., Fidalgo P., Pereira A.D., Gouveia-Oliveira A., Chaves P., Selhub J., Mason J.B., Mira F.C., Leitao C.N. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur. J. Cancer Prev. 1994, 3:473-479.
16. Cravo M.L., Pinto A.G., Chaves P., Cruz J.A., Lage P., Nobre Leitao C., Costa Mira F. Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clin. Nutr. 1998, 17:45-49.
17. Dashwood R.H., Myzak M.C., Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 2006, 27:344-349.
18. Davidson L.A., Wang N., Shah M.S., Lupton J.R., Ivanov I., Chapkin R.S. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 2009, 30:2077-2084.
19. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. 2007, 104:13056-13061.
20. Druesne N., Pagniez A., Mayeur C., Thomas M., Cherbuy C., Duee P.H., Martel P., Chaumontet C. Repetitive treatments of colon HT-29 cells with diallyl disulfide induce a prolonged hyperacetylation of histone H3 K14. Ann. NY Acad. Sci. 2004, 1030:612-621.
21. Druesne-Pecollo N., Chaumontet C., Pagniez A., Vaugelade P., Bruneau A., Thomas M., Cherbuy C., Duee P.H., Martel P. In vivo treatment by diallyl disulfide increases histone acetylation in rat colonocytes. Biochem. Biophys. Res. Commun. 2007, 354:140-147.
22. Duthie S.J., Narayanan S., Blum S., Pirie L., Brand G.M. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr. Cancer 2000, 37:245-251.
23. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
24. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits dna methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63:7563-7570.
25. Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., Yang C.S. Reversal of hypermethylation and reactivation of p16ink4a, rarβ, and mgmt genes by genistein and other isoflavones from soy. Clin. Cancer Res. 2005, 11:7033-7041.
26. Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137:223S-228S.
27. Fischle W., Wang Y., Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 2003, 15:172-183.
28. Fleischauer A.T., Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J. Nutr. 2001, 131:1032S-1040S.
29. Fleischauer A.T., Poole C., Arab L. Garlic consumption and cancer prevention: Meta-analyses of colorectal and stomach cancers. Am. J. Clin. Nutr. 2000, 72:1047-1052.
30. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K., Iyer N.G., Perez-Rosado A. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 2005, 37:391-400.
31. Gaedicke S., Zhang X., Schmelzer C., Lou Y., Doering F., Frank J., Rimbach G. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008, 582:3542-3546.
32. Gamble M.V., Liu X., Ahsan H., Pilsner J.R., Ilievski V., Slavkovich V., Parvez F., Chen Y., Levy D., Factor-Litvak P., Graziano J.H. Folate and arsenic metabolism: A double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am. J. Clin. Nutr. 2006, 84:1093-1101.
33. Gao Z., Xu Z., Hung M.S., Lin Y.C., Wang T., Gong M., Zhi X., Jablon D.M., You L. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res. 2009, 29:2025-2030.
34. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J. Nutr. 2002, 132:2350S-2355S.
35. Gralla M., Camporeale G., Zempleni J. Holocarboxylase synthetase regulates expression of biotin transporters by chromatin remodeling events at the SMVT locus. J. Nutr. Biochem. 2008, 19:400-408.
36. Hinnebusch B.F., Meng S., Wu J.T., Archer S.Y., Hodin R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 2002, 132:1012-1017.
37. Hwang Y.W., Kim S.Y., Jee S.H., Kim Y.N., Nam C.M. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr. Cancer 2009, 61:598-606.
38. Dietary reference intakes for folate, thiamin, riboflavin, niacin, vitamin B12, panthothenic acid, biotin, and choline 1998, Institute of Medicine, National Academies Press, Washington, DC. 1st edn.
39. Izzotti A., Calin G.A., Steele V.E., Cartiglia C., Longobardi M., Croce C.M., De Flora S. Chemoprevention of cigarette smoke-induced alterations of micrornaRNA expression in rat lungs. Cancer Prev. Res. 2010, 3:62-72.
40. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., Henning S.M., Swendseid M.E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 1998, 128:1204-1212.
41. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
42. Jhaveri M.S., Wagner C., Trepel J.B. Impact of extracellular folate levels on global gene expression. Mol. Pharmacol. 2001, 60:1288-1295.
43. Ju J., Lu G., Lambert J.D., Yang C.S. Inhibition of carcinogenesis by tea constituents. Semin. Cancer Biol. 2007, 17:395-402.
44. Juge N., Mithen R.F., Traka M. Molecular basis for chemoprevention by sulforaphane: A comprehensive review. Cell. Mol. Life Sci. 2007, 64:1105-1127.
45. Kang J., Chen J., Shi Y., Jia J., Zhang Y. Curcumin-induced histone hypoacetylation: The role of reactive oxygen species. Biochem. Pharmacol. 2005, 69:1205-1213.
46. Kim Y. Role of folate in colon cancer development and progression. J. Nutr. 2003, 133:3731S-3739S.
47. Kobza K., Camporeale G., Rueckert B., Kueh A., Griffin J.B., Sarath G., Zempleni J. K4, K9 and K18 in human histone H3 are targets for biotinylation by biotinidase. FEBS J. 2005, 272:4249-4259.
48. Li N., Sun Z., Han C., Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc. Soc. Exp. Biol. Med. 1999, 220:218-224.
49. Li Y., Liu L., Andrews L.G., Tollefsbol T.O. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer 2009, 125:286-296.
50. Luebeck E.G., Moolgavkar S.H., Liu A.Y., Boynton A., Ulrich C.M. Does folic acid supplementation prevent or promote colorectal cancer? 2008, Results from model-based predictions, Cancer epidemiol biomarkers prev.
51. Ma X., Fang Y., Beklemisheva A., Dai W., Feng J., Ahmed T., Liu D., Chiao J.W. Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells. Int. J. Oncol. 2006, 28:1287-1293.
52. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 2006, 66:10843-10848.
53. McKay J.A., Williams E.A., Mathers J.C. Gender-specific modulation of tumorigenesis by folic acid supply in the Apc mouse during early neonatal life. Br. J. Nutr. 2008, 99:550-558.
54. Miller J.W., Nadeau M.R., Smith J., Smith D., Selhub J. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem. J. 1994, 298(Pt 2):415-419.
55. Mock D.M., Stadler D.D. Conflicting indicators of biotin status from a cross-sectional study of normal pregnancy. J. Am. Coll. Nutr. 1997, 16:252-257.
56. Mock D.M., Lankford G.L., Mock N.I. Biotin accounts for only half of the total avidin-binding substances in human serum. J. Nutr. 1995, 125:941-946.
57. Mock D.M., Stadler D.D., Stratton S.L., Mock N.I. Biotin status assessed longitudinally in pregnant women. J. Nutr. 1997, 127:710-716.
58. Myzak M.C., Dashwood R.H. Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr. Drug Targets 2006, 7:443-452.
59. Myzak M.C., Dashwood R.H. Chemoprotection by sulforaphane: Keep one eye beyond Keap1. Cancer Lett. 2006, 233:208-218.
60. Myzak M.C., Karplus P.A., Chung F.L., Dashwood R.H. A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase. Cancer Res. 2004, 64:5767-5774.
61. Myzak M.C., Dashwood W.M., Orner G.A., Ho E., Dashwood R.H. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J. 2006, 20:506-508.
62. Myzak M.C., Hardin K., Wang R., Dashwood R.H., Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006, 27:811-819.
63. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H., Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood) 2007, 232:227-234.
64. Negrini M., Nicoloso M.S., Calin G.A. MicroRNAs and cancer-new paradigms in molecular oncology. Curr. Opin. Cell Biol. 2009, 21:470-479.
65. Pledgie-Tracy A., Sobolewski M.D., Davidson N.E. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol. Cancer Ther. 2007, 6:1013-1021.
66. Pogribny I.P., Shpyleva S.I., Muskhelishvili L., Bagnyukova T.V., James S.J., Beland F.A. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutat. Res. 2009, 669:56-62.
67. Qin W., Zhu W., Shi H., Hewett J.E., Ruhlen R.L., MacDonald R.S., Rottinghaus G.E., Chen Y.C., Sauter E.R. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr. Cancer 2009, 61:238-244.
68. Rada-Iglesias A., Enroth S., Ameur A., Koch C.M., Clelland G.K., Respuela-Alonso P., Wilcox S., Dovey O.M., Ellis P.D., Langford C.F., Dunham I., Komorowski J., et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res. 2007, 17:708-719.
69. Rahman I. Dietary polyphenols mediated regulation of oxidative stress and chromatin remodeling in inflammation. Nutr. Rev. 2008, 66(Suppl 1):S42-S45.
70. Rahman I., Marwick J., Kirkham P. Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 2004, 68:1255-1267.
71. Rampersaud G.C., Kauwell G.P., Hutson A.D., Cerda J.J., Bailey L.B. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 2000, 72:998-1003.
72. Sanjoaquin M.A., Allen N., Couto E., Roddam A.W., Key T.J. Folate intake and colorectal cancer risk: A meta-analytical approach. Int. J. Cancer 2005, 113:825-828.
73. Scheppach W., Weiler F. The butyrate story: Old wine in new bottles?. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7:563-567.
74. Scheppach W., Bartram H.P., Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur. J. Cancer 1995, 31A:1077-1080.
75. Shimizu K., Onishi M., Sugata E., Sokuza Y., Mori C., Nishikawa T., Honoki K., Tsujiuchi T. Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats. Cancer Sci. 2007, 98:1318-1322.
76. Shimizu M., Fukutomi Y., Ninomiya M., Nagura K., Kato T., Araki H., Suganuma M., Fujiki H., Moriwaki H. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3020-3025.
77. Shin W., Yan J., Abratte C.M., Vermeylen F., Caudill M.A. Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men. J. Nutr 2010.
78. Song J., Medline A., Mason J.B., Gallinger S., Kim Y. Effects of dietary folate on intestinal tumorigenesis in the apcmin mouse. Cancer Res. 2000, 60:5434-5440.
79. Stanley J.S., Griffin J.B., Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur. J. Biochem. 2001, 268:5424-5429.
80. Stern L.L., Mason J.B., Selhub J., Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev. 2000, 9:849-853.
81. Trock B.J., Hilakivi-Clarke L., Clarke R. Meta-analysis of soy intake and breast cancer risk. J. Natl Cancer Inst. 2006, 98:459-471.
82. Ulrich C.M. Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J. Nutr. 2005, 135:2698-2702.
83. Ulrich C.M. Folate and cancer prevention: A closer look at a complex picture. Am. J. Clin. Nutr. 2007, 86:271-273.
84. Ulrich C.M., Potter J.D. Folate and cancer-timing is everything. JAMA 2007, 297:2408-2409.
85. van Engeland M., Weijenberg M.P., Roemen G.M., Brink M., de Bruine A.P., Goldbohm R.A., van den Brandt P.A., Baylin S.B., de Goeij A.F., Herman J.G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 2003, 63:3133-3137.
86. Walker A.R., Walker B.F., Walker A.J. Faecal pH, dietary fibre intake, and proneness to colon cancer in four South African populations. Br. J. Cancer 1986, 53:489-495.
87. Wang B., Majumder S., Nuovo G., Kutay H., Volinia S., Patel T., Schmittgen T.D., Croce C., Ghoshal K., Jacob S.T. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 2009, 50:1152-1161.
88. Warri A., Saarinen N.M., Makela S., Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer 2008, 98:1485-1493.
89. Waterland R.A., Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 2003, 23:5293-5300.
90. Wu A.H., Yu M.C., Tseng C.C., Pike M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 2008, 98:9-14.
91. Xu W.S., Parmigiani R.B., Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26:5541-5552.
92. Young G.P., Hu Y., Le Leu R.K., Nyskohus L. Dietary fibre and colorectal cancer: A model for environment-gene interactions. Mol. Nutr. Food Res. 2005, 49:571-584.
93. Zempleni J., Helm R.M., Mock D.M. In Vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release. J. Nutr. 2001, 131:1479-1484.
94. Zhang Y., Talalay P., Cho C.G., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 1992, 89:2399-2403.